HYPAQUE-M,75%
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Nov 1955
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HYPAQUE-M 75% is an injectable contrast medium developed by GE HealthCare, approved in 1955 for diagnostic imaging procedures. The product is a methylglucamine diatrizoate formulation used to enhance radiographic visualization of internal body structures. It represents a legacy diagnostic agent from the early era of contrast-based medical imaging.
LOE Approaching
As a nearly 70-year-old diagnostic agent approaching loss of exclusivity, this product likely operates as a legacy cash-generator with a small, stable commercial team focused on defensive maintenance rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on HYPAQUE-M 75% offers limited career growth or visibility, as the product is in terminal lifecycle with no new indication opportunities or clinical expansion. Career value is primarily in contract management, institutional pricing negotiation, and defensive market maintenance rather than innovation or franchise-building.
Product ManagerAccount Manager
Worked on HYPAQUE-M,75% at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.